Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

239
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
239
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

51
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
51
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

83
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
83
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

103
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
103
Nursing Interventions II: Selecting and Classifying the Nursing Interventions01:29

Nursing Interventions II: Selecting and Classifying the Nursing Interventions

2.1K
Creating and executing a nursing diagnosis helps nurses plan care and guide patient, family, and community interventions. They are developed based on a patient's physical evaluation and support measuring the outcomes. It is not recommended to select random interventions throughout the planning process. Instead, consider the following six essential factors when choosing interventions:
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Resource Use and Costs of Nurse Navigator Support for Parents of High-Risk Infants After Discharge from a Neonatal Intensive Care Unit.

Children (Basel, Switzerland)·2026
Same author

Understanding the decision of parents to opt-out of medically actionable secondary findings offered through genome sequencing.

Journal of genetic counseling·2026
Same author

Incorporating Personal Utility in Health Technology Assessment of Emerging Genomic and Genetic Testing Technologies.

The American journal of bioethics : AJOB·2026
Same author

Understanding the impact of genomic secondary findings on clinical care and patient experience: a protocol for a prospective observational study.

BMJ open·2026
Same author

System of Linear Equations to Derive Unreported Test Accuracy Counts for Meta-Analysis.

Statistics in medicine·2025
Same author

Mental disorders among postpartum individuals with medically high-risk infants and/or obstetrical complications: A population requiring further attention.

Paediatrics & child health·2025
Same journal

The Price of National Pharmaceutical Pricing in the EU: A Proposal for "Common Procurement".

Applied health economics and health policy·2026
Same journal

The Price of Speed: Estimating the Impact of List Prices on Time to Availability of New Medicines in 18 European Countries.

Applied health economics and health policy·2026
Same journal

Deprescribing Interventions in Older Adults with Polypharmacy: A Systematic Review of Economic Evaluations.

Applied health economics and health policy·2026
Same journal

Causal Impact of Primary Care and Publicly Funded Health Insurance on Catastrophic Health Spending From Climate-Sensitive Diseases in India.

Applied health economics and health policy·2026
Same journal

Health Economic Evaluations of Breast Cancer Screening Strategies: A Systematic Review Focusing on Methodology and Quality Assessment.

Applied health economics and health policy·2026
Same journal

Societal Preferences for Assessment Pathways of Rare Disease Drugs: A Discrete Choice Experiment.

Applied health economics and health policy·2026
See all related articles

Related Experiment Video

Updated: Jun 12, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

451

Methods and Practical Considerations for Conducting Budget Impact Analysis for Non-Pharmaceutical Interventions.

Xuanqian Xie1, Jennifer Guo2, Alexis K Schaink2

  • 1Health Technology Assessment Program, Ontario Health, 525 University Avenue, 5th Floor, Toronto, ON, M5G 2L3, Canada. shawn.xie@ontariohealth.ca.

Applied Health Economics and Health Policy
|January 17, 2025
PubMed
Summary
This summary is machine-generated.

Budget impact analysis (BIA) for non-pharmaceutical interventions requires careful consideration of healthcare system capacity and intervention uptake factors. Addressing these methodological challenges improves financial impact predictions for public payers.

More Related Videos

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.2K
Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
09:33

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India

Published on: December 23, 2022

2.2K

Related Experiment Videos

Last Updated: Jun 12, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

451
The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.2K
Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
09:33

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India

Published on: December 23, 2022

2.2K

Area of Science:

  • Health economics
  • Health technology assessment
  • Healthcare management

Background:

  • Health technology assessment (HTA) is performed at national, provincial, and hospital levels.
  • Budget impact analysis (BIA) methods for non-pharmaceutical interventions are less explored in literature compared to pharmaceuticals.
  • Provincial and hospital-based HTAs frequently assess non-pharmaceutical interventions.

Purpose of the Study:

  • To review Health Technology Assessments (HTAs) of non-pharmaceutical interventions from a Canadian provincial agency since 2015.
  • To evaluate the characteristics and challenges associated with conducting Budget Impact Analyses (BIAs) for non-pharmaceutical interventions.
  • To provide methodological insights for accurate financial forecasting in healthcare planning.

Main Methods:

  • Systematic review of published HTAs of non-pharmaceutical interventions.
  • Analysis of BIAs conducted by a Canadian provincial HTA agency since 2015.
  • Categorization of interventions (surgery, diagnostics, programs, digital health) to identify unique BIA characteristics.

Main Results:

  • BIAs for non-pharmaceutical interventions necessitate accounting for healthcare system capacity and historical volumes for population estimation.
  • Intervention uptake is influenced by guidelines, implementation requirements (labor, infrastructure), and target population size.
  • Interpreting cost savings requires clarity on their source and reallocation potential, applicable also to pharmaceutical HTAs.

Conclusions:

  • Addressing specific methodological considerations in BIAs for non-pharmaceutical interventions enhances financial impact prediction for public payers.
  • Improved BIA methods can guide effective budget allocation for healthcare system planning.
  • These findings support more robust financial evaluations for a wider range of healthcare technologies.